Skip to content
Hend El Sherbini's offer for Integrated Diagnostics has gone unconditional at 56.6%, days after independent directors told shareholders the price undervalued the company.
IDH chief executive Hend El Sherbini's $291 million bid to take the Egyptian diagnostics group private had drawn no acceptances by July 22.
IDH chief executive Hend El Sherbini and co-investor Moamena Kamel have launched a $291 million bid to take the diagnostics group private and delist it from London.